Dimed S.A. Distribuidora de Medicamentos
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumes, personal hygiene and beauty products, cosmetics, and dermo-cosmetics in Brazil. It sells its products through stores under Panvel brand. The company is also involved in purchasing, selling, brokering, subdividing, leasing, renting, managing and administering its owned and third-party properties. Dimed S.A. Distribuidora de Medica… Read more
Market Cap & Net Worth: Dimed S.A. Distribuidora de Medicamentos (PNVL3)
Dimed S.A. Distribuidora de Medicamentos (SA:PNVL3) has a market capitalization of $356.60 Million (R$2.17 Billion) as of March 18, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #15964 globally and #124 in its home market, demonstrating a -3.90% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dimed S.A. Distribuidora de Medicamentos's stock price R$14.55 by its total outstanding shares 149257015 (149.26 Million).
Dimed S.A. Distribuidora de Medicamentos Market Cap History: 2015 to 2026
Dimed S.A. Distribuidora de Medicamentos's market capitalization history from 2015 to 2026. Data shows growth from $208.69 Million to $356.60 Million (7.47% CAGR).
Index Memberships
Dimed S.A. Distribuidora de Medicamentos is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
SAO PAULO SE IGCX INDEX
IGCX
|
$127.75 Billion | 0.13% | #56 of 155 |
Weight: Dimed S.A. Distribuidora de Medicamentos's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Dimed S.A. Distribuidora de Medicamentos Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dimed S.A. Distribuidora de Medicamentos's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Dimed S.A. Distribuidora de Medicamentos's market cap is 0.04 times its annual revenue
0.84x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
2.04x
Dimed S.A. Distribuidora de Medicamentos's market cap is 2.04 times its annual earnings
11.15x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $208.69 Million | $1.99 Billion | $45.27 Million | 0.11x | 4.61x |
| 2016 | $485.07 Million | $2.13 Billion | $53.06 Million | 0.23x | 9.14x |
| 2017 | $292.95 Million | $2.26 Billion | $59.80 Million | 0.13x | 4.90x |
| 2018 | $230.68 Million | $2.43 Billion | $74.98 Million | 0.09x | 3.08x |
| 2019 | $442.98 Million | $2.72 Billion | $76.75 Million | 0.16x | 5.77x |
| 2020 | $494.97 Million | $2.82 Billion | $56.15 Million | 0.18x | 8.82x |
| 2021 | $306.35 Million | $3.23 Billion | $79.43 Million | 0.09x | 3.86x |
| 2022 | $238.07 Million | $3.99 Billion | $86.34 Million | 0.06x | 2.76x |
| 2023 | $320.12 Million | $4.46 Billion | $92.91 Million | 0.07x | 3.45x |
| 2024 | $215.67 Million | $4.94 Billion | $105.51 Million | 0.04x | 2.04x |
Competitor Companies of PNVL3 by Market Capitalization
Companies near Dimed S.A. Distribuidora de Medicamentos in the global market cap rankings as of March 18, 2026.
Key companies related to Dimed S.A. Distribuidora de Medicamentos by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Dimed S.A. Distribuidora de Medicamentos Historical Marketcap From 2015 to 2026
Between 2015 and today, Dimed S.A. Distribuidora de Medicamentos's market cap moved from $208.69 Million to $ 356.60 Million, with a yearly change of 7.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$356.60 Million | +21.35% |
| 2025 | R$293.86 Million | +36.25% |
| 2024 | R$215.67 Million | -32.63% |
| 2023 | R$320.12 Million | +34.46% |
| 2022 | R$238.07 Million | -22.29% |
| 2021 | R$306.35 Million | -38.11% |
| 2020 | R$494.97 Million | +11.74% |
| 2019 | R$442.98 Million | +92.03% |
| 2018 | R$230.68 Million | -21.26% |
| 2017 | R$292.95 Million | -39.61% |
| 2016 | R$485.07 Million | +132.43% |
| 2015 | R$208.69 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Dimed S.A. Distribuidora de Medicamentos was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $356.60 Million USD |
| MoneyControl | $356.60 Million USD |
| MarketWatch | $356.60 Million USD |
| marketcap.company | $356.60 Million USD |
| Reuters | $356.60 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.